Johnson & Johnson's <br />COVID-19 Vaccine Is <br />66% Effective in Global Trial.<br />The single-shot vaccine was found to be 66% effective against moderate to severe illness in a global phase 3 trial.<br />Against severe disease, the vaccine <br />was 85% effective globally in adults <br />of all ages and racial groups.<br />In the United States, the vaccine was 72% effective <br />against moderate and severe disease.<br />Despite other vaccines being <br />around 95% effective, experts <br />say the Johnson & Johnson <br />vaccine will still be useful.<br />A vaccine that's inexpensive, that's a single dose, and that has no cold chain requirements — that's pretty good. , Dr. Anthony Fauci, via CNN.<br />Johnson & Johnson is set to apply for emergency use <br />authorization through the U.S. Food and Drug Administration <br />next week, hoping for a late February rollout
